Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-15

FDA Approved: HEPARIN SODIUM — Supplemental Application (Sandoz Inc.)

View source ↗

Summary

FDA approved a supplemental application for Heparin Sodium submitted by Sandoz Inc., indicating an additional regulatory action on this generic product under an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

SUPPL AP for HEPARIN SODIUM (HEPARIN SODIUM)